Results of the observational prospective RealFLOT study

Results of the observational prospective RealFLOT study

Abstract Background Perioperative FLOT (5-fluorouracil, oxaliplatin and docetaxel) has recently become the gold standard treatment for fit patients with operable gastric (GC) or gastroesophageal (GEJ) adenocarcinoma, getting a 5-year overall survival (OS) of 45%, over 23% with surgery alone. Methods...

Full description

Bibliographic Details
Main Authors: Elisa Giommoni, Daniele Lavacchi, Giuseppe Tirino, Lorenzo Fornaro, Francesco Iachetta, Carmelo Pozzo, Maria Antonietta Satolli, Andrea Spallanzani, Marco Puzzoni, Silvia Stragliotto, Michele Sisani, Vincenzo Formica, Filippo Giovanardi, Antonia Strippoli, Michele Prisciandaro, Samantha Di Donato, Luca Pompella, Irene Pecora, Alessandra Romagnani, Sara Fancelli, Marco Brugia, Serena Pillozzi, Ferdinando De Vita, Lorenzo Antonuzzo
Format: Article
Language:English
Published: BMC 2021-10-01
Series:BMC Cancer
Subjects:
FLOT
Perioperative chemotherapy
Gastric cancer
Gastro-oesophageal junction adenocarcinoma
pCR
MSI
Online Access:https://doi.org/10.1186/s12885-021-08768-7

Internet

https://doi.org/10.1186/s12885-021-08768-7

Similar Items